AMAG Pharmaceuticals, Inc. stock price

AMAG Pharmaceuticals, Inc. latest news:


  • 02/15/2018 05:13:14

    Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector

    Shares of Antares Pharma Inc. and Amag Pharmaceuticals soared in premarket trade Thursday, after Amag said the U.S. Food and Drug Administration has approved their Makena subcutaneous auto injector drug-device combination product, a ready-to-administer treatment to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past. Under the terms of a deal agreed between the two companies in 2014, Amag will make and supply the drug product to Antares, which will manufacture the device, assemble and package it for sale to Amag at cost plus margin. Antares will receive high single digit to low double digit royalties on sales and be eligible for milestone payments. Antares shares soared 26%, while Amag shares were up 19%. S&P 500 futures were up 0.5%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Amarin Corporation PLCAMRN | A-Mark Precious Metals, Inc.AMRK | Amaya Inc.AYA | Amazon.com, Inc.AMZN | Ambac Financial Group, Inc.AMBC | Ambac Financial Group, Inc.AMBCW | Ambarella, Inc.AMBA | Ambassadors Group, Inc.EPAX | AMC Networks Inc.AMCX | Amdocs LimitedDOX |